Skip to main content
Clinical Trials/NCT05504109
NCT05504109
Unknown
Not Applicable

Minimally Invasive Mitral Valve Replacement Versus Conventional Approach: Comparison of Early Postoperative Outcomes.

Sohag University1 site in 1 country50 target enrollmentSeptember 1, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Minimally Invasive Mitral Valve Surgery
Sponsor
Sohag University
Enrollment
50
Locations
1
Primary Endpoint
post-operative pain
Last Updated
3 years ago

Overview

Brief Summary

The term minimally invasive mitral valve surgery has been reported (MIMVS) by American Heart Association and referred to a collection of new techniques. All of these new techniques aiming to reduce surgical trauma by minimizing surgical incision, modified perfusion methods and use of new instruments . The right anterior mini-thoracotomy is the most common approach, next to it the lower mini-sternotomy approach, then the parasternal incision or the left posterior thoracotomy approach .

Technically MIMVS is more complex, requires a special learning curve and associated with higher Incidence of neurological events, aortic dissection, groin complications and infection despite all these benefits . MIVS also has controversies among cardiac surgeons, because it makes the exposure worse and requires a more complex surgery, which may lead to a less satisfying effect

Registry
clinicaltrials.gov
Start Date
September 1, 2022
End Date
April 1, 2023
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

abdelhamed alaaeldin ali

Assistant lecture of cardiothoracic surgery

Sohag University

Eligibility Criteria

Inclusion Criteria

  • Patients with isolated rheumatic mitral valve disease in need for mitral valve replacement.

Exclusion Criteria

  • Redo mitral valve replacement.
  • Emergency mitral valve replacement (non-rheumatic cases).
  • Patients who have combined other valve diseases e.g. (severe Aortic Regurgitation).
  • Patients need Tricuspid valve repair or replacement.
  • Severely calcified mitral valve disease (mitral annular calcification).

Outcomes

Primary Outcomes

post-operative pain

Time Frame: immediately post operative

pain score

total hospital stay in days

Time Frame: maximum 7 days

days in hospital included ICU stay and ward stay

Study Sites (1)

Loading locations...

Similar Trials